EFFECT OF HELICOBACTER-PYLORI ERADICATION ON THE HEALING AND RECURRENCE OF PEPTIC-ULCER - COMBINATION THERAPY WITH LOW-DOSE OMEPRAZOLE AND CLARITHROMYCIN
N. Uemura et al., EFFECT OF HELICOBACTER-PYLORI ERADICATION ON THE HEALING AND RECURRENCE OF PEPTIC-ULCER - COMBINATION THERAPY WITH LOW-DOSE OMEPRAZOLE AND CLARITHROMYCIN, European journal of gastroenterology & hepatology, 7, 1995, pp. 67-69
Aim: To investigate the effect of eradication of Helicobacter pylori u
sing combination therapy with low-dose omeprazole and clarithromycin o
n the healing and recurrence of peptic ulcers. Patients and methods: W
e studied 60 patients with active duodenal ulcers and 60 with gastric
ulcers who were H. pylori-positive by the rapid urease test and a hist
ological examination of antral biopsy specimens. The eradication metho
d used was a combination of omeprazole (20 mg a day) and clarithromyci
n (400 mg twice a day). The patients were followed up for 24 months af
ter the end of the treatment. H. pylori infection and the ulcer stage
were investigated by endoscopy every 6 months. We assessed the relatio
nship between H. pylori infection, ulcer healing to a white scar and u
lcer recurrence after combination therapy. Results: H. pylori was erad
icated in 23 out of 120 patients (22%), with suppression in 101 out of
120 patients (84%). The rate of ulcer healing to a white scar 6 month
s after treatment was significantly higher and the ulcer recurrence ra
te within 2 years after treatment was significantly lower in patients
with H. pylori suppression or eradication than in those continuously p
ositive for the organism. Conclusions: These results suggest that not
only the eradication but also the suppression of H. pylori may improve
ulcer healing and reduce the rate of relapse.